Literature DB >> 10837420

Membrane and transmembrane signaling in Herpesvirus saimiri-transformed human CD4(+) and CD8(+) T lymphocytes is ATM-independent.

M Rivero-Carmena1, O Porras, B Pelaez, A Pacheco-Castro, R A Gatti, J R Regueiro.   

Abstract

In the genetic disorder ataxia telangiectasia (AT), humoral (B) and cellular (T) immunological abnormalities are frequently observed. As a consequence, AT patients are predisposed to life-threatening sinopulmonary infections. The pathogenic mechanisms remain unknown, but a role for ATM in signal transduction from membrane receptors has been proposed. We have explored the effects of a defective ATMgene on isolated human T-lineage cells from 13 AT patients with proven T cell dysfunction by transforming their CD4(+) and CD8(+) T lymphocytes with Herpesvirus saimiri, and analyzing their signaling behavior as compared to normal controls. Several functional parameters were assayed in response to both membrane (anti-CD3 and IL-2) and transmembrane (phorbol myristate acetate plus the calcium ionophore ionomycin) stimuli: (i) calcium mobilization, (ii) induction of activation molecules (CD25, CD40 ligand, CD69 and CD71), (iii) cytokine synthesis (IL-2 and tumor necrosis factor-alpha) and (iv) proliferation. All these early and late activation events were found to be normal in the transformed ATM-/-T cells, indicating that ATM is not necessary for their induction. As expected, ATM-/- transformed T cells showed an increased radiosensitivity by both radioresistant DNA synthesis and cell survival assays. In contrast to an earlier report testing transformed B lymphocytes, our results indicate that transformed mature peripheral T lymphocytes from AT patients do not have intrinsic immune function defects. Rather, the described T-lineage signaling impairments observed in patients may be secondary in vivo to extrinsic ATM-dependent suppressive factors and/or to a developmental defect. These transformed T cells may help to understand the distinct biological role of ATM in different cell types and to develop rational therapies for the immunological dysfunction of AT patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837420     DOI: 10.1093/intimm/12.6.927

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

Review 1.  The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone.

Authors:  R A Gatti; S Becker-Catania; H H Chun; X Sun; M Mitui; C H Lai; N Khanlou; M Babaei; R Cheng; C Clark; Y Huo; N C Udar; R K Iyer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  Characterization of Herpesvirus saimiri-transformed T lymphocytes from common variable immunodeficiency patients.

Authors:  J A Cabanillas; R Cambronero; A Pacheco-Castro; M C García-Rodríguez; J M Martín-Fernández; G Fontán; J R Regueiro
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

3.  Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia.

Authors:  R Schubert; J Reichenbach; S Zielen
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

4.  Immunodeficiency, radiosensitivity, and the XCIND syndrome.

Authors:  Richard A Gatti; Elena Boder; Robert A Good
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

5.  Antibody response to a seven-valent pneumococcal conjugated vaccine in patients with ataxia-telangiectasia.

Authors:  Ozden Sanal; Fugen Ersoy; Ilhan Tezcan; Ayse Metin; Tuba Turul; Semra Gariboglu; Leman Yel
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

6.  Critical involvement of the ATM-dependent DNA damage response in the apoptotic demise of HIV-1-elicited syncytia.

Authors:  Jean-Luc Perfettini; Roberta Nardacci; Mehdi Bourouba; Frédéric Subra; Laurent Gros; Claire Séror; Gwenola Manic; Filippo Rosselli; Alessandra Amendola; Peggy Masdehors; Luciana Chessa; Giuseppe Novelli; David M Ojcius; Jan Konrad Siwicki; Magdalena Chechlinska; Christian Auclair; José R Regueiro; Hugues de Thé; Marie-Lise Gougeon; Mauro Piacentini; Guido Kroemer
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

Review 7.  Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?

Authors:  Moussab Tatfi; Olivier Hermine; Felipe Suarez
Journal:  Front Immunol       Date:  2019-01-04       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.